Skip to content

Onconetix, Inc.: 10-Q filed 2026-08-13

What Onconetix, Inc. reported in its quarterly report filed 2026-08-13 (fiscal Q2 2026): 44 published measures, 128 facts as tagged in accession 0001213900-26-089093.

This filing

Form
10-Q (quarterly report)
Filed
2026-08-13
Fiscal period
fiscal Q2 2026
Accession
0001213900-26-089093 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Onconetix, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2026-06-3016,426,341USD
At 2025-12-3124,926,638USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2026-06-302,956,108USD
At 2025-12-319,160,287USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2026-06-3013,468,509USD
At 2026-03-3111,746,477USD
At 2025-12-3115,764,627USD
At 2025-06-305,909,761USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-2,867,303USD91
2026-01-01 to 2026-06-30-7,082,178USD181
2026-01-01 to 2026-03-31-4,214,875USD90
2025-04-01 to 2025-06-30-2,372,442USD91
2025-01-01 to 2025-06-30-10,918,327USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-4,039,548USD181
2025-01-01 to 2025-06-30-3,409,976USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2026-04-01 to 2026-06-3017,120USD91
2026-01-01 to 2026-06-3038,577USD181
2025-04-01 to 2025-06-30106,494USD91
2025-01-01 to 2025-06-30208,124USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2026-01-01 to 2026-06-304,800,163USD181
2025-01-01 to 2025-06-303,614,828USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2026-06-30-138,296,736USD
At 2025-12-31-131,214,558USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2026-04-01 to 2026-06-302,242,770shares91
2026-01-01 to 2026-06-301,158,993shares181
2025-04-01 to 2025-06-3011,353shares91
2025-01-01 to 2025-06-307,843shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2026-04-01 to 2026-06-302,242,770shares91
2026-01-01 to 2026-06-301,158,993shares181
2025-04-01 to 2025-06-3011,353shares91
2025-01-01 to 2025-06-307,843shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-1.28USD/shares91
2026-01-01 to 2026-06-30-6.11USD/shares181
2025-04-01 to 2025-06-30-237.91USD/shares91
2025-01-01 to 2025-06-30-1,583.19USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-1.28USD/shares91
2026-01-01 to 2026-06-30-6.11USD/shares181
2025-04-01 to 2025-06-30-237.91USD/shares91
2025-01-01 to 2025-06-30-1,583.19USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2026-06-3028,655USD
At 2025-12-3137,085USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2026-01-01 to 2026-06-3029,664USD181
2025-01-01 to 2025-06-3060,238USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-2,730,790USD91
2026-01-01 to 2026-06-30-12,956,591USD181
2025-04-01 to 2025-06-30-1,935,418USD91
2025-01-01 to 2025-06-30-14,506,247USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2026-06-306,517,810USD
At 2025-12-316,066,774USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2026-06-302,943,793USD
At 2025-12-319,135,925USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2026-06-301,844,861USD
At 2025-12-311,757,695USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2026-06-309,618,142USD
At 2026-03-3110,203,473USD
At 2025-12-3118,549,005USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2026-06-302,351USD
At 2025-12-31296,866USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2026-04-01 to 2026-06-302,735,093USD91
2026-01-01 to 2026-06-3012,959,239USD181
2025-04-01 to 2025-06-302,005,921USD91
2025-01-01 to 2025-06-3014,622,582USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2026-06-30210,448USD
At 2025-12-31149,961USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2026-04-01 to 2026-06-304,303USD91
2026-01-01 to 2026-06-302,648USD181
2025-04-01 to 2025-06-3070,503USD91
2025-01-01 to 2025-06-30116,335USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2026-04-01 to 2026-06-3012,817USD91
2026-01-01 to 2026-06-3035,929USD181
2025-04-01 to 2025-06-3035,991USD91
2025-01-01 to 2025-06-3091,789USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2026-04-01 to 2026-06-302,245,653USD91
2026-01-01 to 2026-06-304,284,981USD181
2025-04-01 to 2025-06-301,523,591USD91
2025-01-01 to 2025-06-303,197,797USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2026-06-303,793,673shares
At 2025-12-3131,198shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2026-06-305,942,249USD
At 2025-12-315,220,654USD
At 2025-06-30283,515USD
At 2024-12-31646,500USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2026-06-30152,959,715USD
At 2025-12-31147,836,004USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2026-06-30-568,717USD
At 2025-12-31-231,028USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2026-06-3013,468,509USD
At 2025-12-3115,764,627USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2026-06-3036,734USD
At 2025-12-3148,774USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2026-06-30249,607USD
At 2025-12-31341,881USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2026-06-30362,762USD
At 2025-12-31349,293USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-2,867,303USD91
2026-01-01 to 2026-06-30-7,082,178USD181
2025-04-01 to 2025-06-30-2,372,442USD91
2025-01-01 to 2025-06-30-10,918,327USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-2,994,820USD91
2026-01-01 to 2026-06-30-7,419,867USD181
2025-04-01 to 2025-06-30-144,660USD91
2025-01-01 to 2025-06-30-8,580,276USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-2,867,303USD91
2026-01-01 to 2026-06-30-7,082,178USD181
2025-04-01 to 2025-06-30-2,700,946USD91
2025-01-01 to 2025-06-30-12,416,922USD181

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2026-04-01 to 2026-06-304,389USD91
2026-01-01 to 2026-06-306,633USD181
2025-04-01 to 2025-06-30223,097USD91
2025-01-01 to 2025-06-30446,689USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2026-04-01 to 2026-06-304,747USD91
2026-01-01 to 2026-06-30-12,063USD181
2025-04-01 to 2025-06-30-22,660USD91
2025-01-01 to 2025-06-30-28,023USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-136,513USD91
2026-01-01 to 2026-06-305,874,413USD181
2025-04-01 to 2025-06-30-437,024USD91
2025-01-01 to 2025-06-303,587,920USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2026-01-01 to 2026-06-306,633USD181
2025-01-01 to 2025-06-30184,546USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2026-01-01 to 2026-06-304,265,275USD181
2025-01-01 to 2025-06-306,391,655USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-312,185USD181
2025-01-01 to 2025-06-30-15,685USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2026-01-01 to 2026-06-3064,593USD181
2025-01-01 to 2025-06-3072,765USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2026-01-01 to 2026-06-3087,337USD181
2025-01-01 to 2025-06-30-272,801USD181

Inspect the source

Entity
Onconetix, Inc. / CIK 0001782107
Captured
SEC response SHA-256
8853d40ab3bc9b0b28d644990b0d8b93bfdb4ec13654d313eee955e0eae089fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001782107.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))